XYL
Xylem Inc.
XYL's fundamentals are strong and it looks cheap: trading at 21x earnings, about half its usual 40x. Analysts expect earnings growth.
XYL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
XYL's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
XYL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $94.03 | — |
| Current | 21x | $94.03 | — |
| Cheap | 32x | $143 | +52% |
| Fair | 40x | $182 | +94% |
| Expensive | 62x | $278 | +196% |
Historical ranges are pointers, not guarantees.
XYL's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
XYL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect XYL's earnings to grow and its profitability to improve, with its revenue holding steady.
XYL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.62 | +24% |
| Q3 2026 | $4.52 | +16% |
| Q2 2026 | $4.20 | +9.4% |
| Q1 2026 | $4.02 | +8.4% |
| Q4 2025 | $3.92 | +7.4% |
| Q3 2025 | $3.88 | +11% |
| Q2 2025 | $3.84 | +19% |
| Q1 2025 | $3.71 | +29% |
| Q4 2024 | $3.65 | +31% |
XYL's earnings per share have climbed steadily: $4.52 over the past year, up 16% from the year before, and higher year over year for 13 quarters in a row.
XYL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | -3% |
| Q2 2026 | $2.3B | +1.5% |
| Q1 2026 | $2.1B | +2.7% |
| Q4 2025 | $2.4B | +6.3% |
| Q3 2025 | $2.3B | +7.8% |
| Q2 2025 | $2.3B | +6.1% |
| Q1 2025 | $2.1B | +1.8% |
| Q4 2024 | $2.3B | +6.5% |
XYL's revenue grew through 2024 and has held roughly level since: $2.2B last quarter, down 3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +2.8 points |
| Q2 2026 | 17% | +3.4 points |
| Q1 2026 | 11% | +0.3 points |
| Q4 2025 | 15% | +2.9 points |
| Q3 2025 | 15% | +1.4 points |
| Q2 2025 | 13% | +1.6 points |
| Q1 2025 | 11% | +0.9 points |
| Q4 2024 | 12% | +1.9 points |
XYL's operating margin was 17% last quarter, up 2.8 points from the same quarter a year ago, near the top of its range since 2019.
XYL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $242M | -14% |
| Q2 2026 | $201M | -2.9% |
| Q1 2026 | $18M | +$56M |
| Q4 2025 | $460M | -3.2% |
| Q3 2025 | $281M | +19% |
| Q2 2025 | $207M | -3.7% |
| Q1 2025 | -$38M | -353% |
| Q4 2024 | $475M | +32% |
XYL generated $921M in free cash flow over the past year, about the same as the year before.
XYL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -3.5M shares |
| 1 year | -4.5% | -11.1M shares |
| 3 years | -3.8% | -9.1M shares |
| 5 years | +28% | +51.4M shares |
| Available history | +29% | +51.8M shares |
XYL has 233M diluted shares, down 4.5% from a year ago, with $1.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $337M |
| Q2 2026 | $680M |
| Q1 2026 | $563M |
| Q4 2025 | $1M |
| Q3 2025 | $1M |
| Q2 2025 | — |
| Q1 2025 | $13M |
| Q4 2024 | $1M |
XYL spent $1.6B buying back its own shares over the past year, more than ten times what it spent the year before.
XYL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.6x | Very low |
XYL's net debt is about 1.1 years of its operating earnings (EBITDA), up from less than a year a year ago.
XYL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.6 | Neutral |
| Stochastic | 19.7 | Oversold |
XYL's weekly RSI is 35 (neutral) and its Stochastic is 20 (oversold).
XYL PE vs Industrials Sector
| Metric | XYL | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 24x | 13% below |
| PE % | 0 | 58 | 58 pts below |
XYL is trading at 21x earnings, a 13% discount to the Industrials sector's median of 24x.
XYL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $100.5 | 6.5% below |
| 20 week MA | $109.4 | 14% below |
| 50 week MA | $119.0 | 21% below |
| 100 week MA | $124.8 | 25% below |
| 200 week MA | $120.7 | 22% below |
XYL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
XYL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $78.8 | $100.3 | +27% |
| 2021 | $100.3 | $117.5 | +17% |
| 2022 | $117.5 | $109.7 | -6.6% |
| 2023 | $109.7 | $114.4 | +4.2% |
| 2024 | $114.4 | $117.5 | +2.8% |
| 2025 | $117.5 | $138.8 | +18% |
| 2026 YTD | $138.8 | $94.0 | -32% |
XYL is down 32% so far in 2026, after finishing higher in five of the previous six years.